STRIDES PHARMA SCIENCE Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Quarterly Results    (PLLB)

Here are the latest quarterly results of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE financial fact sheet and STRIDES PHARMA SCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

STRIDES PHARMA SCIENCE Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
3
Dec-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,1867,8187,9368,3209,0856,8847,2157,944 
Other income Rs m177162178144130186222102 
Turnover Rs m6,3637,9808,1138,4649,2157,0707,4378,046 
Expenses Rs m5,5366,3086,3636,7267,5137,4377,3507,929 
Gross profit Rs m-1,0511,9591,7031,4561,563-1,469-735-139 
Depreciation Rs m453491528525519549566609 
Interest Rs m403369369347416415436423 
Profit before tax Rs m-1,7311,261984728759-2,246-1,514-1,069 
Tax Rs m-1053361108115-355-68-45 
Profit after tax Rs m-1,6261,228923621644-1,890-1,446-1,024 
Gross profit margin %-17.025.121.517.517.2-21.3-10.2-1.8 
Effective tax rate %6.02.66.214.815.115.84.54.2 
Net profit margin %-26.315.711.67.57.1-27.5-20.0-12.9 
Diluted EPS Rs -18.1 13.7 10.3 6.9 7.2 -21.1 -16.1 -11.4  
Diluted EPS (TTM) Rs 16.8 25.6 18.7 12.8 38.0 3.3 -23.1 -41.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Views on news

The Most Oversold Stocks in India. Is it Finally Time to Get in? (Views On News)

Jan 7, 2022

With the help of relative strength index (RSI), we take a look at top stocks that are oversold at current levels.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


May 20, 2022 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - ACTAVIS COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS